07 Jan 2001

Hadensa pomada - España

Updated: 07 Jan 2001

Hadensa pomada 42 g

Hemorroides, prurito anal. Fisura anal, proctitis.

Hadensa pomada Description, Presentation and Dosage

Hadensa pomada Description

Hadensa pomada Drug Class Description

Antihemorroidales topicos sin corticoides

Hadensa pomada Drug Description


Hadensa pomada Presentation

Hadensa pomada Presentation

Pomada: 3 veces al día, y después de cada deposición. Supositorios: 2 supositorios al día, uno al acostarse y otro al levantarse.

Hadensa pomada Manufacturer


Related Learning Zones

Heart Failure

Heart Failure is a progressive chronic disorder that results in the inability of the heart to pump blood efficiently to the bodys tissues.

Chronic heart failure is an increasing public health problem; the growing prevalence in industrialised countries means that 1-2% of the adult population of these countries are now thought to have chronic heart failure.1-3 Estimates suggest that the prevalence in Europe, USA and Japan could increase by approximately 16.5% over the next ten years.4

Type 2 Diabetes

Type 2 Diabetes

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

Hadensa pomada Dosage

Hadensa pomada Precautions, Reactions and Contraindications

Hadensa pomada Special Precautions

Related Drugs - Cardiología

Back to top